These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11906279)

  • 1. Design, synthesis, and evaluation of opioid analogues with non-peptidic beta-turn scaffold: enkephalin and endomorphin mimetics.
    Eguchi M; Shen RY; Shea JP; Lee MS; Kahn M
    J Med Chem; 2002 Mar; 45(7):1395-8. PubMed ID: 11906279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six highly active mu-selective opioid peptides identified from two synthetic combinatorial libraries.
    Dooley CT; Kaplan RA; Chung NN; Schiller PW; Bidlack JM; Houghten RA
    Pept Res; 1995; 8(3):124-37. PubMed ID: 7670227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational and topographical considerations in the design of biologically active peptides.
    Hruby VJ
    Biopolymers; 1993 Jul; 33(7):1073-82. PubMed ID: 8102072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly potent side-chain to side-chain cyclized enkephalin analogues containing a carbonyl bridge: synthesis, biology and conformation.
    Pawlak D; Oleszczuk M; Wójcik J; Pachulska M; Chung NN; Schiller PW; Izdebski J
    J Pept Sci; 2001 Mar; 7(3):128-40. PubMed ID: 11297348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-peptides: twisting and turning.
    Gademann K; Hintermann T; Schreiber JV
    Curr Med Chem; 1999 Oct; 6(10):905-25. PubMed ID: 10519905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective opioid dipeptides.
    Temussi PA; Salvadori S; Amodeo P; Bianchi C; Guerrini R; Tomatis R; Lazarus LH; Picone D; Tancredi T
    Biochem Biophys Res Commun; 1994 Feb; 198(3):933-9. PubMed ID: 8117299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parallel synthesis and biological evaluation of different sizes of bicyclo[2,3]-Leu-enkephalin analogues.
    Gu X; Ying J; Min B; Cain JP; Davis P; Willey P; Navratilova E; Yamamura HI; Porreca F; Hruby VJ
    Biopolymers; 2005; 80(2-3):151-63. PubMed ID: 15660379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudoproline-containing analogues of morphiceptin and endomorphin-2: evidence for a cis Tyr-Pro amide bond in the bioactive conformation.
    Keller M; Boissard C; Patiny L; Chung NN; Lemieux C; Mutter M; Schiller PW
    J Med Chem; 2001 Nov; 44(23):3896-903. PubMed ID: 11689075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of enkephalin and dermorphin into delta-selective opioid antagonists by single-residue substitution.
    Tancredi T; Salvadori S; Amodeo P; Picone D; Lazarus LH; Bryant SD; Guerrini R; Marzola G; Temussi PA
    Eur J Biochem; 1994 Aug; 224(1):241-7. PubMed ID: 8076645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and receptor binding of opioid peptide analogues containing beta3-homo-amino acids.
    Wilczyńska D; Kosson P; Kwasiborska M; Ejchart A; Olma A
    J Pept Sci; 2009 Nov; 15(11):777-82. PubMed ID: 19787815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution conformation of [D-Pen2, D-Pen5] enkephalin in water: a NMR and molecular dynamics study.
    Gussmann M; Borsdorf R; Hofmann HJ
    J Pept Sci; 1996; 2(6):351-6. PubMed ID: 9230462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformationally readdressed CCK-B/delta-opioid peptide ligands.
    Nikiforovich GV; Kolodziej SA; Nock B; Bernad N; Martinez J; Marshall GR
    Biopolymers; 1995 Oct; 36(4):439-52. PubMed ID: 7578939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a model for the delta-opioid receptor pharmacophore: 3. Comparison of the cyclic tetrapeptide, Tyr-c[D-Cys-Phe-D-Pen]OH with other conformationally constrained delta-receptor selective ligands.
    Lomize AL; Pogozheva ID; Mosberg HI
    Biopolymers; 1996 Feb; 38(2):221-34. PubMed ID: 8589255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endomorphin 1[psi] and endomorphin 2[psi], endomorphins analogues containing a reduced (CH2NH) amide bond between Tyr1 and Pro2, display partial agonist potency but significant antinociception.
    Zhao QY; Chen Q; Yang DJ; Feng Y; Long Y; Wang P; Wang R
    Life Sci; 2005 Jul; 77(10):1155-65. PubMed ID: 15878600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive peptidomimetic libraries targeting protein-protein interactions.
    Whitby LR; Boger DL
    Acc Chem Res; 2012 Oct; 45(10):1698-709. PubMed ID: 22799570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topochemical design of bioactive peptides and peptidomimetics.
    Goodman M; Ro S; Yamazaki T; Spencer JR; Toy A; Huang Z; He Y; Reisine T
    Bioorg Khim; 1992; 18(10-11):1375-93. PubMed ID: 1363715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational analysis of the endogenous mu-opioid agonist endomorphin-1 using NMR spectroscopy and molecular modeling.
    Podlogar BL; Paterlini MG; Ferguson DM; Leo GC; Demeter DA; Brown FK; Reitz AB
    FEBS Lett; 1998 Nov; 439(1-2):13-20. PubMed ID: 9849868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endomorphin-2 with a beta-turn backbone constraint retains the potent micro-opioid receptor agonist properties.
    Tömböly C; Ballet S; Feytens D; Kövér KE; Borics A; Lovas S; Al-Khrasani M; Fürst Z; Tóth G; Benyhe S; Tourwé D
    J Med Chem; 2008 Jan; 51(1):173-7. PubMed ID: 18062664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newly discovered stereochemical requirements in the side-chain conformation of delta opioid agonists for recognizing opioid delta receptors.
    Qian X; Kövér KE; Shenderovich MD; Lou BS; Misicka A; Zalewska T; Horváth R; Davis P; Bilsky EJ; Porreca F
    J Med Chem; 1994 Jun; 37(12):1746-57. PubMed ID: 8021915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topological exploration of cyclic endomorphin-1 analogues, structurally defined models for investigating the bioactive conformation of MOR agonists.
    Gentilucci L; Tolomelli A; Squassabia F
    Protein Pept Lett; 2007; 14(1):51-6. PubMed ID: 17266651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.